📣 VC round data is live. Check it out!

Reckitt Valuation Multiples

Discover revenue and EBITDA valuation multiples for Reckitt and similar public comparables like Haleon, Bayer, Kenvue, Estee Lauder and more.

Reckitt Overview

About Reckitt

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or number-two position in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 35% of sales from emerging markets.


Founded

2007

HQ

United Kingdom

Employees

35.1K

Financials (LTM)

Revenue: $18B
EBITDA: $5B

EV

$47B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Reckitt Financials

Reckitt reported last 12-month revenue of $18B and EBITDA of $5B.

In the same LTM period, Reckitt generated $11B in gross profit, $5B in EBITDA, and $3B in net income.

Revenue (LTM)


Reckitt P&L

In the most recent fiscal year, Reckitt reported revenue of $19B and EBITDA of $6B.

Reckitt is profitable as of last fiscal year, with gross margin of 61%, EBITDA margin of 34%, and net margin of 22%.

See analyst estimates for Reckitt
LTMLast FY202320242025202620272028
Revenue$18B$19B$20B$19B$19B
Gross Profit$11B$12B$12B$12B$12B
Gross Margin61%61%60%61%61%
EBITDA$5B$6B$4B$4B$6B
EBITDA Margin29%34%22%21%34%
EBIT Margin25%25%23%24%24%
Net Profit$3B$4B$2B$2B$4B
Net Margin17%22%11%10%22%
Net Debt-$9B---

Financial data powered by Morningstar, Inc.

Reckitt Stock Performance

Reckitt has current market cap of $38B, and enterprise value of $47B.

Market Cap Evolution


Reckitt's stock price is $60.40.

Reckitt share price decreased by 2.2% in the last 30 days, and by 12.4% in the last year.

Reckitt has an EPS (earnings per share) of $6.72.

See more trading valuation data for Reckitt
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$47B$38B-2.2%-2.2%-12.6%-12.4%$6.72

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Reckitt Valuation Multiples

Reckitt trades at 2.6x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Reckitt

EV / Revenue (LTM)


Reckitt Financial Valuation Multiples

As of June 3, 2026, Reckitt has market cap of $38B and EV of $47B.

Reckitt has a P/E ratio of 12.5x.

LTMLast FY202320242025202620272028
EV/Revenue2.6x2.5x2.4x2.5x2.5x
EV/EBITDA9.0x7.4x11.1x11.9x7.4x
EV/EBIT10.5x10.1x10.5x10.2x10.3x
EV/Gross Profit4.3x4.1x4.0x4.1x4.1x
P/E12.5x9.0x17.4x20.0x9.0x
EV/FCF19.2x18.3x16.1x15.9x20.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Reckitt Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Reckitt Margins & Growth Rates

Reckitt decreased revenue by 10% and EBITDA by 25% in the last fiscal year.

In the most recent fiscal year, Reckitt reported gross margin of 61%, EBITDA margin of 34%, and net margin of 22%.

See estimated margins and future growth rates for Reckitt

Reckitt Margins

Last FY202420252026202720282029
Gross Margin61%61%61%62%
EBITDA Margin34%21%34%28%
EBIT Margin25%24%24%25%
Net Margin22%10%22%17%
FCF Margin14%16%12%14%

Reckitt Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(10%)(3%)0%(10%)
Gross Profit Growth(9%)(2%)0%(9%)
EBITDA Growth(25%)(7%)61%(25%)
EBIT Growth(9%)3%(1%)(7%)
Net Profit Growth(33%)(13%)123%(33%)
FCF Growth(10%)1%(24%)3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Reckitt Operational KPIs

Reckitt's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Reckitt's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Reckitt's Rule of X is 2% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Reckitt
LTMLast FY202320242025202620272028
Rule of 4025%18%---
Bessemer Rule of X19%2%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue24%25%25%25%25%
G&A Expenses to Revenue10%10%9%9%9%
R&D Expenses to Revenue2%2%2%2%2%
Opex to Revenue-37%37%36%37%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Reckitt Competitors

Reckitt competitors include Haleon, Bayer, Kenvue, Estee Lauder, Henkel, Galderma, Hindustan Unilever, Church & Dwight, Ulta Beauty and Essity.

Most Reckitt public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Haleon3.3x3.2x12.7x12.4x
Bayer1.4x1.4x6.5x6.6x
Kenvue2.7x2.7x11.9x11.4x
Estee Lauder2.5x2.4x18.4x15.0x
Henkel1.3x1.3x7.3x7.2x
Galderma9.7x9.0x42.1x36.8x
Hindustan Unilever7.6x7.5x30.9x31.9x
Church & Dwight3.9x4.0x17.3x17.1x

This data is available for Pro users. Sign up to see all Reckitt competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Reckitt

When was Reckitt founded?Reckitt was founded in 2007.
Where is Reckitt headquartered?Reckitt is headquartered in United Kingdom.
How many employees does Reckitt have?As of today, Reckitt has over 35K employees.
Who is the CEO of Reckitt?Reckitt's CEO is Kris Licht.
Is Reckitt publicly listed?Yes, Reckitt is a public company listed on London Stock Exchange.
What is the stock symbol of Reckitt?Reckitt trades under RKT ticker.
When did Reckitt go public?Reckitt went public in 2007.
Who are competitors of Reckitt?Reckitt main competitors include Haleon, Bayer, Kenvue, Estee Lauder, Henkel, Galderma, Hindustan Unilever, Church & Dwight, Ulta Beauty, Essity.
What is the current market cap of Reckitt?Reckitt's current market cap is $38B.
What is the current revenue of Reckitt?Reckitt's last 12 months revenue is $18B.
What is the current revenue growth of Reckitt?Reckitt revenue growth (NTM/LTM) is (4%).
What is the current EV/Revenue multiple of Reckitt?Current revenue multiple of Reckitt is 2.6x.
What is the current EBITDA of Reckitt?Reckitt's last 12 months EBITDA is $5B.
What is Reckitt's EBITDA margin?Reckitt's last 12 months EBITDA margin is 29%.
What is the current EV/EBITDA multiple of Reckitt?Current EBITDA multiple of Reckitt is 9.0x.
What is the current FCF of Reckitt?Reckitt's last 12 months FCF is $2B.
What is Reckitt's FCF margin?Reckitt's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Reckitt?Current FCF multiple of Reckitt is 19.2x.
How many companies Reckitt has acquired to date?Reckitt hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Reckitt has invested to date?Reckitt hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Reckitt

Lists including Reckitt

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial